Stephen H. Parsons
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, Microtubule and mitosis dynamics, 14-3-3 protein interactions
Most-Cited Works
- → The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor–Positive Metastatic Breast Cancer(2020)412 cited
- → Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity(2007)377 cited
- → Synthesis and Activity of New Aryl- and Heteroaryl-Substituted Pyrazole Inhibitors of the Transforming Growth Factor-β Type I Receptor Kinase Domain(2003)237 cited
- → Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the RB1 Tumor Suppressor Gene(2018)229 cited
- → eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival(2009)197 cited
- → Therapeutic Inhibition of MAP Kinase Interacting Kinase Blocks Eukaryotic Initiation Factor 4E Phosphorylation and Suppresses Outgrowth of Experimental Lung Metastases(2011)188 cited
- → Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-β type I receptor kinase domain(2004)162 cited
- Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.(2000)
- → Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity(2013)116 cited
- → Redox Regulation of the DNA Repair Function of the Human AP Endonuclease Ape1/ref-1(2001)93 cited